The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Designing Chemically Modified Oligonucleotides for Targeted Gene Silencing
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Sequence-Selective Recognition of DNA by Strand Displacement with a Thymine-Substituted Polyamide
Nielsen, P. E., Egholm, M., Berg, R. H., & Buchardt, O. (1991) · Science · doi:10.1126/science.1962210 · Cited by 3,332
Toll-like receptors in innate immunity
Takeda, K. (2004) · International Immunology · doi:10.1093/intimm/dxh186 · Cited by 3,328
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Sonenberg, N., & Hinnebusch, A. G. (2009) · Cell · doi:10.1016/j.cell.2009.01.042 · Cited by 3,304
Asymmetry in the Assembly of the RNAi Enzyme Complex
Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922
Argonaute2 is the catalytic engine of mammalian RNAi
Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J.-J., Hammond, S. M., Joshua-Tor, L., & Hannon, G. J. (2004) · Science · doi:10.1126/science.1102513 · Cited by 2,796
Functional siRNAs and miRNAs exhibit strand bias
Khvorova, A., Reynolds, A., & Jayasena, S. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00801-8 · Cited by 2,645
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
Keefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules
Egholm, M., Buchardt, O., Christensen, L., Behrens, C., Freier, S. M., Driver, D. A., Berg, R. H., Kim, S. K., Norden, B., & Nielsen, P. E. (1993) · Nature · doi:10.1038/365566a0 · Cited by 2,079
Altona, C., & Sundaralingam, M. (1972) · Journal of the American Chemical Society · doi:10.1021/ja00778a043 · Cited by 2,056
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs
Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., & Tuschl, T. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.007 · Cited by 2,052
Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi
Martinez, J., Patkaniowska, A., Urlaub, H., Lührmann, R., & Tuschl, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00908-x · Cited by 1,459
Bennett, C. F., & Swayze, E. E. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,374
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,232
Passenger-Strand Cleavage Facilitates Assembly of siRNA into Ago2-Containing RNAi Enzyme Complexes
Matranga, C., Tomari, Y., Shin, C., Bartel, D. P., & Zamore, P. D. (2005) · Cell · doi:10.1016/j.cell.2005.08.044 · Cited by 1,211
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
Morpholino Antisense Oligomers: Design, Preparation, and Properties
SUMMERTON, J., & WELLER, D. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.187 · Cited by 1,116
Koshkin, A. A., Singh, S. K., Nielsen, P., Rajwanshi, V. K., Kumar, R., Meldgaard, M., Olsen, C. E., & Wengel, J. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00094-5 · Cited by 1,047
Immunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity
Jackson, A. L., Burchard, J., Schelter, J., Chau, B. N., Cleary, M., Lim, L., & Linsley, P. S. (2006) · RNA · doi:10.1261/rna.25706 · Cited by 956
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J. Z., Albuquerque, R. J. C., Yamasaki, S., Itaya, M., Pan, Y., et al. (2008) · Nature · doi:10.1038/nature06765 · Cited by 929
Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.
Stephenson, M. L., & Zamecnik, P. C. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.285 · Cited by 906
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
Kim, D.-H., Behlke, M. A., Rose, S. D., Chang, M.-S., Choi, S., & Rossi, J. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1051 · Cited by 884
siRNA function in RNAi: A chemical modification analysis
CHIU, Y.-L., & RANA, T. M. (2003) · RNA · doi:10.1261/rna.5103703 · Cited by 860
RNA-Based Therapeutics: Current Progress and Future Prospects
Burnett, J. C., & Rossi, J. J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.008 · Cited by 819
Ribonuclease H: the enzymes in eukaryotes
Cerritelli, S. M., & Crouch, R. J. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.06908.x · Cited by 814
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 789
A three-dimensional view of the molecular machinery of RNA interference
Jinek, M., & Doudna, J. A. (2009) · Nature · doi:10.1038/nature07755 · Cited by 744
Stability of peptide nucleic acids in human serum and cellular extracts
Demidov, V. V., Potaman, V. N., Frank-Kamenetskil, M. D., Egholm, M., Buchard, O., Sönnichsen, S. H., & Nlelsen, P. E. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90171-6 · Cited by 737
Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain
Ma, J.-B., Ye, K., & Patel, D. J. (2004) · Nature · doi:10.1038/nature02519 · Cited by 732
Obika, S., Nanbu, D., Hari, Y., Andoh, J.-I., Morio, K.-I., Doi, T., & Imanishi, T. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)01084-3 · Cited by 700
The Crystal Structure of Human Argonaute2
Schirle, N. T., & MacRae, I. J. (2012) · Science · doi:10.1126/science.1221551 · Cited by 696
Progress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
Structural basis for 5′-nucleotide base-specific recognition of guide RNA by human AGO2
Frank, F., Sonenberg, N., & Nagar, B. (2010) · Nature · doi:10.1038/nature09039 · Cited by 666
Morpholino antisense oligomers: the case for an RNase H-independent structural type
Summerton, J. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00150-5 · Cited by 664
siRNA vs. shRNA: Similarities and differences
Rao, D. D., Vorhies, J. S., Senzer, N., & Nemunaitis, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.004 · Cited by 660
Structural basis for 5′-end-specific recognition of guide RNA by the A. fulgidus Piwi protein
Ma, J.-B., Yuan, Y.-R., Meister, G., Pei, Y., Tuschl, T., & Patel, D. J. (2005) · Nature · doi:10.1038/nature03514 · Cited by 657
Humphreys, D. T., Westman, B. J., Martin, D. I. K., & Preiss, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506482102 · Cited by 655
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells
Czauderna, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg393 · Cited by 623
Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA
Braasch, D. A., & Corey, D. R. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00058-2 · Cited by 605
A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans
Kennedy, S., Wang, D., & Ruvkun, G. (2004) · Nature · doi:10.1038/nature02302 · Cited by 592
Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex
Wang, Y., Juranek, S., Li, H., Sheng, G., Tuschl, T., & Patel, D. J. (2008) · Nature · doi:10.1038/nature07666 · Cited by 577
Current concepts in antisense drug design
Milligan, J. F., Matteucci, M. D., & Martin, J. C. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00066a001 · Cited by 566
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality
Elm n, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki193 · Cited by 559
Structure of the guide-strand-containing argonaute silencing complex
Wang, Y., Sheng, G., Juranek, S., Tuschl, T., & Patel, D. J. (2008) · Nature · doi:10.1038/nature07315 · Cited by 543
Nucleation, propagation and cleavage of target RNAs in Ago silencing complexes
Wang, Y., Juranek, S., Li, H., Sheng, G., Wardle, G. S., Tuschl, T., & Patel, D. J. (2009) · Nature · doi:10.1038/nature08434 · Cited by 542
Tolerance for mutations and chemical modifications in a siRNA
Amarzguioui, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg147 · Cited by 534
RNA Interference in Mammalian Cells by Chemically-Modified RNA
Braasch, D. A., Jensen, S., Liu, Y., Kaur, K., Arar, K., White, M. A., & Corey, D. R. (2003) · Biochemistry · doi:10.1021/bi0343774 · Cited by 531
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
Wahlestedt, C., Salmi, P., Good, L., Kela, J., Johnsson, T., Hökfelt, T., Broberger, C., Porreca, F., Lai, J., Ren, K., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5633 · Cited by 520
Kawamata, T., & Tomari, Y. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.03.009 · Cited by 481
Evidence that siRNAs Function as Guides, Not Primers, in the Drosophila and Human RNAi Pathways
Schwarz, D. S., Hutvágner, G., Haley, B., & Zamore, P. D. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00651-2 · Cited by 471
Silencing disease genes in the laboratory and the clinic
Watts, J. K., & Corey, D. R. (2012) · The Journal of Pathology · doi:10.1002/path.2993 · Cited by 470
Specificity, duplex degradation and subcellular localization of antagomirs
Krützfeldt, J., Kuwajima, S., Braich, R., Rajeev, K. G., Pena, J., Tuschl, T., Manoharan, M., & Stoffel, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm024 · Cited by 455
Kawasaki, A. M., Casper, M. D., Freier, S. M., Lesnik, E. A., Zounes, M. C., Cummins, L. L., Gonzalez, C., & Cook, P. D. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00059a007 · Cited by 438
Chemical modification and design of anti-miRNA oligonucleotides
Lennox, K. A., & Behlke, M. A. (2011) · Gene Therapy · doi:10.1038/gt.2011.100 · Cited by 433
Chemically modified siRNA: tools and applications
Watts, J. K., Deleavey, G. F., & Damha, M. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.05.007 · Cited by 431
Self-citationImproved targeting of miRNA with antisense oligonucleotides
Davis, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl183 · Cited by 422
RISC is a 5′ phosphomonoester-producing RNA endonuclease
Martinez, J., & Tuschl, T. (2004) · Genes & Development · doi:10.1101/gad.1187904 · Cited by 407
Cleavage of the siRNA passenger strand during RISC assembly in human cells
Leuschner, P. J. F., Ameres, S. L., Kueng, S., & Martinez, J. (2006) · EMBO reports · doi:10.1038/sj.embor.7400637 · Cited by 399
Gene therapy progress and prospects: non-viral gene therapy by systemic delivery
Li, S.-D., & Huang, L. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302838 · Cited by 391
Phosphorothioate Oligodeoxynucleotides: What Is Their Origin and What Is Unique About Them?
ECKSTEIN, F. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.2000.10.117 · Cited by 382
Baker, B. F., Lot, S. S., Condon, T. P., Cheng-Flournoy, S., Lesnik, E. A., Sasmor, H. M., & Bennett, C. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.11994 · Cited by 371
Bramsen, J. B., Laursen, M. B., Nielsen, A. F., Hansen, T. B., Bus, C., Langkjær, N., Babu, B. R., Højland, T., Abramov, M., Van Aerschot, A., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp106 · Cited by 369
Stein, C. A., Hansen, J. B., Lai, J., Wu, S., Voskresenskiy, A., H⊘g, A., Worm, J., Hedtjärn, M., Souleimanian, N., Miller, P., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp841 · Cited by 360
Activation of the mammalian immune system by siRNAs
Marques, J. T., & Williams, B. R. G. (2005) · Nature Biotechnology · doi:10.1038/nbt1161 · Cited by 358
Kastelein, J. J. P., Wedel, M. K., Baker, B. F., Su, J., Bradley, J. D., Yu, R. Z., Chuang, E., Graham, M. J., & Crooke, R. M. (2006) · Circulation · doi:10.1161/circulationaha.105.606442 · Cited by 358
Determination of the Role of the Human RNase H1 in the Pharmacology of DNA-like Antisense Drugs
Wu, H., Lima, W. F., Zhang, H., Fan, A., Sun, H., & Crooke, S. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311683200 · Cited by 349
Manoharan, M. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00138-4 · Cited by 348
Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice
Judge, A. D., Robbins, M., Tavakoli, I., Levi, J., Hu, L., Fronda, A., Ambegia, E., McClintock, K., & MacLachlan, I. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37515 · Cited by 336
RNA interference using boranophosphate siRNAs: structure-activity relationships
Hall, A. H. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh936 · Cited by 285
Positional Effect of Chemical Modifications on Short Interference RNA Activity in Mammalian Cells
Prakash, T. P., Allerson, C. R., Dande, P., Vickers, T. A., Sioufi, N., Jarres, R., Baker, B. F., Swayze, E. E., Griffey, R. H., & Bhat, B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050044o · Cited by 285
Overcoming the Innate Immune Response to Small Interfering RNA
Judge, A., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.179 · Cited by 284
Campbell, M. A., & Wengel, J. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15048k · Cited by 279
Stein, H., & Hausen, P. (1969) · Science · doi:10.1126/science.166.3903.393 · Cited by 257
Current Protocols in Nucleic Acid Chemistry
(2018) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/(issn)1934-9289 · Cited by 248
Marquez, V. E., Siddiqui, M. A., Ezzitouni, A., Russ, P., Wang, J., Wagner, R. W., & Matteucci, M. D. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960306+ · Cited by 247
Kawai, G., Yamamoto, Y., Kamimura, T., Masegi, T., Sekine, M., Hata, T., Iimori, T., Watanabe, T., Miyazawa, T., & Yokoyama, S. (1992) · Biochemistry · doi:10.1021/bi00119a012 · Cited by 239
Peptide Nucleic Acids (PNA) in Chemical Biology and Drug Discovery
Nielsen, P. E. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.201000005 · Cited by 236
An Overview of Sugar‐Modified Oligonucleotides for Antisense Therapeutics
Prakash, T. P. (2011) · Chemistry & Biodiversity · doi:10.1002/cbdv.201100081 · Cited by 218
Progress Toward In Vivo Use of siRNAs-II
Rettig, G. R., & Behlke, M. A. (2012) · Molecular Therapy · doi:10.1038/mt.2011.263 · Cited by 217
siRNA and isRNA: two edges of one sword
Schlee, M., Hornung, V., & Hartmann, G. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.06.001 · Cited by 216
Advantages of 2'-O-methyl oligoribonucleotide probes for detecting RNA targets
Majlessi, M. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.9.2224 · Cited by 213
The human RNA kinase hClp1 is active on 3′ transfer RNA exons and short interfering RNAs
Weitzer, S., & Martinez, J. (2007) · Nature · doi:10.1038/nature05777 · Cited by 211
Exploring Chemical Modifications for siRNA Therapeutics: A Structural and Functional Outlook
Shukla, S., Sumaria, C. S., & Pradeepkumar, P. I. (2010) · ChemMedChem · doi:10.1002/cmdc.200900444 · Cited by 210
Unexpected origins of the enhanced pairing affinity of 2′-fluoro-modified RNA
Pallan, P. S., Greene, E. M., Jicman, P. A., Pandey, R. K., Manoharan, M., Rozners, E., & Egli, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1270 · Cited by 199
Improved silencing properties using small internally segmented interfering RNAs
Bramsen, J. B., Laursen, M. B., Damgaard, C. K., Lena, S. W., Ravindra Babu, B., Wengel, J., & Kjems, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm548 · Cited by 192
Silencing or Stimulation? siRNA Delivery and the Immune System
Whitehead, K. A., Dahlman, J. E., Langer, R. S., & Anderson, D. G. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114133 · Cited by 191
Wilds, C. J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.18.3625 · Cited by 188
Improvements in siRNA properties mediated by 2'-deoxy-2'-fluoro- -D-arabinonucleic acid (FANA)
Dowler, T. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl033 · Cited by 188
Morpholino antisense oligonucleotides: tools for investigating vertebrate development.
Corey, D. R., & Abrams, J. (2001) · Genome biology · doi:10.1186/gb-2001-2-5-reviews1015 · Cited by 188
CpG Still Rocks! Update on an Accidental Drug
Krieg, A. M. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0340 · Cited by 187
Lönnberg, H. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800406a · Cited by 187
Manoharan, M. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760070849 · Cited by 185
Evaluation of locked nucleic acid–modified small interfering RNA in vitro and in vivo
Mook, O. R., Baas, F., de Wissel, M. B., & Fluiter, K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0195 · Cited by 182
The evolution of our thinking about microRNAs
Ambros, V. (2008) · Nature Medicine · doi:10.1038/nm1008-1036 · Cited by 179
Hybrids of RNA and Arabinonucleic Acids (ANA and 2‘F-ANA) Are Substrates of Ribonuclease H
Damha, M. J., Wilds, C. J., Noronha, A., Brukner, I., Borkow, G., Arion, D., & Parniak, M. A. (1998) · Journal of the American Chemical Society · doi:10.1021/ja982325+ · Cited by 179
Self-citationUi-Tei, K., Naito, Y., Zenno, S., Nishi, K., Yamato, K., Takahashi, F., Juni, A., & Saigo, K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn042 · Cited by 176
Strand-invasion of duplex DNA by peptide nucleic acid oligomers.
Peffer, N. J., Hanvey, J. C., Bisi, J. E., Thomson, S. A., Hassman, C. F., Noble, S. A., & Babiss, L. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10648 · Cited by 172
Structure of C3PO and mechanism of human RISC activation
Ye, X., Huang, N. N., Liu, Y., Paroo, Z., Huerta, C., Li, P., Chen, S., Liu, Q., & Zhang, H. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2032 · Cited by 168
Antisense therapeutics: is it as simple as complementary base recognition?
Agrawal, S., & Kandimalla, E. R. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01638-x · Cited by 166
Peptide nucleic acid (PNA) — a review
Shakeel, S., Karim, S., & Ali, A. (2006) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.1505 · Cited by 162
siRNA Repositioning for Guide Strand Selection by Human Dicer Complexes
Noland, C. L., Ma, E., & Doudna, J. A. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.028 · Cited by 157
Kalota, A., Karabon, L., Swider, C. R., Viazovkina, E., Elzagheid, M., Damha, M. J., & Gewirtz, A. M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj455 · Cited by 151
Self-citationKubiak, K., Sochacka, E., Kaźmierczak-Barańska, J., Maszewska, M., Janicka, M., Nowak, G., & Nawrot, B. (2007) · RNA · doi:10.1261/rna.538907 · Cited by 149
MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity
Turner, J. J., Jones, S. W., Moschos, S. A., Lindsay, M. A., & Gait, M. J. (2006) · Molecular BioSystems · doi:10.1039/b611612d · Cited by 146
Kraynack, B. A., & Baker, B. F. (2005) · RNA · doi:10.1261/rna.2150806 · Cited by 144
Accessing the therapeutic potential of immunostimulatory nucleic acids
Barchet, W., Wimmenauer, V., Schlee, M., & Hartmann, G. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.07.007 · Cited by 131
Rational design and in vitro and in vivo delivery of Dicer substrate siRNA
Amarzguioui, M., Lundberg, P. S., Cantin, E. M., Hagstrom, J. E., Behlke, M. A., & Rossi, J. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.72 · Cited by 131
Therapeutic applications of ribozymes and riboswitches
Mulhbacher, J., St-Pierre, P., & Lafontaine, D. A. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.07.002 · Cited by 130
The Chemistry and Biology of Oligonucleotide Conjugates
Juliano, R. L., Ming, X., & Nakagawa, O. (2012) · Accounts of Chemical Research · doi:10.1021/ar2002123 · Cited by 129
Dande, P., Prakash, T. P., Sioufi, N. B., Gaus, H. J., Jarres, R., Berdeja, A., Swayze, E. E., Griffey, R. H., & Bhat, B. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050822c · Cited by 122
Berger, I., Tereshko, V. A., Ikeda, H., Márquez, V. E., & Egli, M. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.10.2473 · Cited by 118
Eckstein, F. (1966) · Journal of the American Chemical Society · doi:10.1021/ja00970a054 · Cited by 116
Fauster, K., Hartl, M., Santner, T., Aigner, M., Kreutz, C., Bister, K., Ennifar, E., & Micura, R. (2012) · ACS Chemical Biology · doi:10.1021/cb200510k · Cited by 114
Recent advances of siRNA delivery by nanoparticles
Yuan, X., Naguib, S., & Wu, Z. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.559223 · Cited by 113
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
Rigo, F., Hua, Y., Chun, S. J., Prakash, T. P., Krainer, A. R., & Bennett, C. F. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.939 · Cited by 111
Improved specificity of gene silencing by siRNAs containing unlocked nucleobase analogs
Vaish, N. K., Chen, F., Seth, S., Fosnaugh, K. L., Liu, Y., Adami, R. C., Brown, T., Chen, Y., Harvie, P., Johns, R. E., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq961 · Cited by 111
Relative Flexibility of DNA and RNA: a Molecular Dynamics Study
Noy, A., Pérez, A., Lankaš, F., Luque, F. J., & Orozco, M. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.07.048 · Cited by 110
Dumbbell-Shaped Nanocircular RNAs for RNA Interference
Abe, N., Abe, H., & Ito, Y. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0754453 · Cited by 105
Anzahaee, M. Y., Watts, J. K., Alla, N. R., Nicholson, A. W., & Damha, M. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja109817p · Cited by 102
Self-citationChemical Modification of siRNA Bases To Probe and Enhance RNA Interference
Peacock, H., Kannan, A., Beal, P. A., & Burrows, C. J. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo2012225 · Cited by 100
Functional relevance of miRNA* sequences in human disease
Bhayani, M. K., Călin, G. A., & Lai, S. Y. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.10.014 · Cited by 97
Deleavey, G. F., Watts, J. K., Alain, T., Robert, F., Kalota, A., Aishwarya, V., Pelletier, J., Gewirtz, A. M., Sonenberg, N., & Damha, M. J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq181 · Cited by 97
Self-citationChemical Modification of siRNA
Deleavey, G. F., Watts, J. K., & Damha, M. J. (2009) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc1603s39 · Cited by 91
Self-citationDuplex stabilities of phosphorothioate, methylphosphonate, and RNA analogs of two DNA 14-mers
Kibler-Herzog, L., Zon, G., Uznański, B., Whittier, G., & Wilson, W. D. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.11.2979 · Cited by 91
Mangos, M., Min, K., Viazovkina, E., Galarneau, A., Elzagheid, M. I., Parniak, M. A., & Damha, M. J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja025557o · Cited by 90
Self-citationLima, W. F., Rose, J. B., Nichols, J. G., Wu, H., Migawa, M. T., Wyrzykiewicz, T. K., Siwkowski, A. M., & Crooke, S. T. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025015 · Cited by 89
An Exocyclic Methylene Group Acts As a Bioisostere of the 2′-Oxygen Atom in LNA
Seth, P. P., Allerson, C. R., Berdeja, A., Siwkowski, A. M., Pallan, P. S., Gaus, H. J., Prakash, T. P., Watt, A. T., Egli, M., & Swayze, E. E. (2010) · Journal of the American Chemical Society · doi:10.1021/ja105875e · Cited by 86
Watts, J. K., Martín‐Pintado, N., Gómez‐Pinto, I., Schwartzentruber, J., Portella, G., Orozco, M., González, C., & Damha, M. J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1225 · Cited by 85
Self-citationGene Silencing Activity of siRNAs with a Ribo-difluorotoluyl Nucleotide
Xia, J. L., Noronha, A. M., Toudjarska, I., Li, F., Akinc, A., Braich, R. S., Frank-Kamenetsky, M. D., Rajeev, K. G., Egli, M., & Manoharan, M. (2006) · ACS Chemical Biology · doi:10.1021/cb600063p · Cited by 85
Structure, Recognition Properties, and Flexibility of the DNA·RNA Hybrid
Noy, A., Pérez, A., Márquez, M., Luque, F. J., & Orozco, M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja043293v · Cited by 84
Dicer is dispensable for asymmetric RISC loading in mammals
Betancur, J. G., & Tomari, Y. (2012) · RNA · doi:10.1261/rna.029785.111 · Cited by 84
Inhibition of MDR1 expression with altritol-modified siRNAs
FISHER, M. S., Abramov, M., Aerschot, A. A. V., Xu, D., Juliano, R. L., & Herdewijn, P. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1126 · Cited by 81
Aigner, M., Hartl, M., Fauster, K., Steger, J., Bister, K., & Micura, R. (2010) · ChemBioChem · doi:10.1002/cbic.201000646 · Cited by 78
2′-Fluoro-4′-thioarabino-modified oligonucleotides: conformational switches linked to siRNA activity
Watts, J. K., Choubdar, N., Sadalapure, K., Robert, F., Wahba, A. S., Pelletier, J., Pinto, B. M., & Damha, M. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1153 · Cited by 78
Self-citationModulation of thermal stability can enhance the potency of siRNA
Addepalli, H., Meena, M., Peng, C. G., Wang, G., Fan, Y., Charissé, K., Jayaprakash, K. N., Rajeev, K. G., Pandey, R. K., Lavine, G., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq568 · Cited by 76
RNA interference: a chemist's perspective
Gaynor, J. W., Campbell, B. J., & Cosstick, R. (2010) · Chemical Society Reviews · doi:10.1039/b920362c · Cited by 76
Solid-Phase Chemical Synthesis of Phosphonoacetate and Thiophosphonoacetate Oligodeoxynucleotides
Dellinger, D. J., Sheehan, D. M., Christensen, N. K., Lindberg, J. G., & Caruthers, M. H. (2003) · Journal of the American Chemical Society · doi:10.1021/ja027983f · Cited by 75
Argonaute and the Nuclear RNAs: New Pathways for RNA-Mediated Control of Gene Expression
Gagnon, K. T., & Corey, D. R. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0330 · Cited by 72
2′F-Arabinonucleic acids (2′F-ANA) — History, properties, and new frontiers
Watts, J. K., & Damha, M. J. (2008) · Canadian Journal of Chemistry · doi:10.1139/v08-049 · Cited by 69
Self-citationOligonucleotide N3′→P5′ Phosphoramidates and Thio‐Phoshoramidates as Potential Therapeutic Agents
Gryaznov, S. M. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900187 · Cited by 69
Developments in RNA chemistry, a personal view
Eckstein, F. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01459-1 · Cited by 68
A Status Update of Modified Oligonucleotides for Chemotherapeutics Applications
Sanghvi, Y. S. (2011) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc0401s46 · Cited by 67
Studies on the hydrolytic stability of 2′-fluoroarabinonucleic acid (2′F-ANA)
Watts, J. K., Katolik, A., Viladoms, J., & Damha, M. J. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b900443b · Cited by 67
Self-citationBoranophosphates Support the RNase H Cleavage of Polyribonucleotides
Rait, V. K., & Shaw, B. R. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.53 · Cited by 64
Ho, M., Vivo, M. D., Peraro, M. D., & Klein, M. L. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102933y · Cited by 59
RNase H mediated cleavage of RNA by cyclohexene nucleic acid (CeNA)
Verbeure, B. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.24.4941 · Cited by 59
Sabatino, D. A., & Damha, M. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja071336c · Cited by 58
Self-citationBiochemical properties of phosphonoacetate and thiophosphonoacetate oligodeoxyribonucleotides
Sheehan, D. M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg439 · Cited by 57
Synthesis of 2′-O-modified adenosine building blocks and application for RNA interference
Odadzic, D., Bramsen, J. B., Smičius, R., Bus, C., Kjems, J., & Engels, J. W. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.09.019 · Cited by 56
Zamanian-Daryoush, M., Marques, J. T., Gantier, M. P., Behlke, M. A., John, M., Rayman, P. A., Finke, J. H., & Williams, B. R. G. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2007.0090 · Cited by 51
Wahba, A. S., Azizi, F., Deleavey, G. F., Brown, C. M., Robert, F., Carrier, M., Kalota, A., Gewirtz, A. M., Pelletier, J., Hudson, R. H. E., et al. (2011) · ACS Chemical Biology · doi:10.1021/cb200070k · Cited by 50
Self-citationNauwelaerts, K., Fisher, M., Froeyen, M., Lescrinier, E., Aerschot, A. A. V., Xu, D., DeLong, R. K., Kang, H., Juliano, R. L., & Herdewijn, P. A. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067047q · Cited by 47
Principles of Dicer Substrate (D-siRNA) Design and Function
Amarzguioui, M., & Rossi, J. J. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-191-8_1 · Cited by 46
mRNA knockdown by single strand RNA is improved by chemical modifications
Haringsma, H. J., Li, J., Soriano, F., Kenski, D. M., Flanagan, W. M., & Willingham, A. T. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1301 · Cited by 46
Gore, K. R., Nawale, G. N., Harikrishna, S., Chittoor-Vinod, V. G., Pandey, S. K., Höbartner, C., Patankar, S., & Pradeepkumar, P. I. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo202666m · Cited by 46
Biological effects of hexitol and altritol-modified siRNAs targeting B-Raf
FISHER, M. S., Abramov, M., Aerschot, A. A. V., Rozenski, J., Dixit, V., Juliano, R. L., & Herdewijn, P. A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.030 · Cited by 45
MicroRNAs as new player in rheumatoid arthritis
Duroux-Richard, I., Présumey, J., Courties, G., Gay, S., Gordeladze, J. O., Jørgensen, C., Kyburz, D., & Apparailly, F. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.06.003 · Cited by 45
RNA Interference in Mammalia Cells by RNA-3’-PNA Chimeras
Potenza, N., Moggio, L., Milano, G., Salvatore, V., Blasio, B. D., Russo, A., & Messere, A. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9030299 · Cited by 45
Overview of Alternative Oligonucleotide Chemistries for Exon Skipping
Saleh, A. F. A., Arzumanov, A. A., & Gait, M. J. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-767-5_23 · Cited by 44
Theoretical Analysis of Antisense Duplexes: Determinants of the RNase H Susceptibility
Noy, A., Luque, F. J., & Orozco, M. (2008) · Journal of the American Chemical Society · doi:10.1021/ja076734u · Cited by 38
Threlfall, R., Torres, A. G., Krivenko, A. A., Gait, M. J., & Caruthers, M. H. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob06614e · Cited by 35
Min, K., Viazovkina, E., Galarneau, A., Parniak, M. A., & Damha, M. J. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00439-0 · Cited by 35
Self-citationRNA Interference Tolerates 2′‐Fluoro Modifications at the Argonaute2 Cleavage Site
Muhonen, P., Tennilä, T., Azhayeva, E., Parthasarathy, R. N., Janckila, A. J., Väänänen, H. K., Azhayev, A. V., & Laitala‐Leinonen, T. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790073 · Cited by 32
Terrazas, M., Ocampo, S. M., Perales, J. C., Márquez, V. E., & Eritja, R. (2011) · ChemBioChem · doi:10.1002/cbic.201000791 · Cited by 32
Steric Effects in RNA Interference: Probing the Influence of Nucleobase Size and Shape
Somoza, Á., Silverman, A. P., Miller, R. M., Chelliserrykattil, J., & Kool, E. T. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200800837 · Cited by 31
Leydier, C., Bellon, L., Barascut, J., Morvan, F., Rayner, B., & Imbach, J. (1995) · Antisense Research and Development · doi:10.1089/ard.1995.5.167 · Cited by 29
Du, L., & Gatti, R. A. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.12.001 · Cited by 28
New peptide nucleic acid analogues: synthesis and applications
Pensato, S., Saviano, M., & Romanelli, A. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.8.1219 · Cited by 27
Improving gene silencing of siRNAs via tricyclo-DNA modification
Ittig, D., Luisier, S., Weiler, J., Schümperli, D., & Leumann, C. J. (2010) · Artificial DNA PNA & XNA · doi:10.4161/adna.1.1.11385 · Cited by 18
Synthesis and Biological Activity of Phosphonocarboxylate DNA
Yamada, C. M., Dellinger, D. J., & Caruthers, M. H. (2007) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770701489896 · Cited by 16
Kannan, A., Fostvedt, E., Beal, P. A., & Burrows, C. J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2003878 · Cited by 12
Bioinformatic Approaches to siRNA Selection and Optimization
Muhonen, P., & Holthöfer, H. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-588-0_6 · Cited by 11
Viazovkina, E., Mangos, M., Elzagheid, M. I., & Damha, M. J. (2002) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc0415s10 · Cited by 10
Self-citationStructure and Function of RNase H Enzymes
Hollis, T., & Shaban, N. M. (2011) · Nucleic acids and molecular biology · doi:10.1007/978-3-642-21078-5_12 · Cited by 7
Cited by
Seeman, N. C., & Sleiman, H. F. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.68 · Cited by 1,875
The chemical evolution of oligonucleotide therapies of clinical utility
Khvorova, A., & Watts, J. K. (2017) · Nature Biotechnology · doi:10.1038/nbt.3765 · Cited by 1,216
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Hendel, A., Bak, R. O., Clark, J. T., Kennedy, A. B., Ryan, D. E., Roy, S., Steinfeld, I., Lunstad, B. D., Kaiser, R. J., Wilkens, A. B., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3290 · Cited by 1,090
Nair, J. K., Willoughby, J. L. S., Chan, A., Charisse, K., Alam, M. R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A. V., Milstein, S., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505986a · Cited by 1,141
Non-coding RNAs as drug targets
Matsui, M., & Corey, D. R. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.117 · Cited by 1,032
Metadata
- Authors
- Deleavey, G. F., & Damha, M. J.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 19
- Issue
- 8
- Pages
- 937-954
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W2057519110
- Cited by
- 589
- References
- 186
- FWCI
- 15.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.